PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

LILLY USA, LLC

IN · US

pharmaceuticals company

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$120,000

Connections

2

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$120K
MMMMedicare/Medicaid
$120K

Lobbying Firms Retained

CROSSROADS STRATEGIES, LLC$120K

Bills Referenced in Lobbying Filings

insulin

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Employed byCROSSROADS STRATEGIES, LLCHired CROSSROADS STRATEGIES, LLC to lobby on PharmaceuticalsSource
Lobbied forInsulin Price Caps - State-Level LegislationLDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000Source